Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Structural and Aggregation Features of a Human κ-Casein Fragment with Antitumor and Cell-Penetrating Properties.

Chinak OA, Shernyukov AV, Ovcherenko SS, Sviridov EA, Golyshev VM, Fomin AS, Pyshnaya IA, Kuligina EV, Richter VA, Bagryanskaya EG.

Molecules. 2019 Aug 12;24(16). pii: E2919. doi: 10.3390/molecules24162919.

2.

Cytotoxic and Antitumor Activity of Lactaptin in Combination with Autophagy Inducers and Inhibitors.

Bagamanshina AV, Troitskaya OS, Nushtaeva AA, Yunusova AY, Starykovych MO, Kuligina EV, Kit YY, Richter M, Wohlfromm F, Kähne T, Lavrik IN, Richter VA, Koval OA.

Biomed Res Int. 2019 Jun 17;2019:4087160. doi: 10.1155/2019/4087160. eCollection 2019.

3.

Establishment of primary human breast cancer cell lines using "pulsed hypoxia" method and development of metastatic tumor model in immunodeficient mice.

Nushtaeva AA, Karpushina AA, Ermakov MS, Gulyaeva LF, Gerasimov AV, Sidorov SV, Gayner TA, Yunusova AY, Tkachenko AV, Richter VA, Koval OA.

Cancer Cell Int. 2019 Feb 28;19:46. doi: 10.1186/s12935-019-0766-5. eCollection 2019.

4.

Characterization of primary normal and malignant breast cancer cell and their response to chemotherapy and immunostimulatory agents.

Nushtaeva AA, Stepanov GA, Semenov DV, Juravlev ES, Balahonova EA, Gerasimov AV, Sidorov SV, Savelyev EI, Kuligina EV, Richter VA, Koval OA.

BMC Cancer. 2018 Jul 9;18(1):728. doi: 10.1186/s12885-018-4635-8.

5.

Variety of RNAs in Peripheral Blood Cells, Plasma, and Plasma Fractions.

Savelyeva AV, Kuligina EV, Bariakin DN, Kozlov VV, Ryabchikova EI, Richter VA, Semenov DV.

Biomed Res Int. 2017;2017:7404912. doi: 10.1155/2017/7404912. Epub 2017 Jan 3.

6.

Artificial Analogues of Circulating Box C/D RNAs Induce Strong Innate Immune Response and MicroRNA Activation in Human Adenocarcinoma Cells.

Stepanov GA, Filippova JA, Nushtaeva AA, Kuligina EV, Koval OA, Richter VA, Semenov DV.

Adv Exp Med Biol. 2016;924:121-125.

PMID:
27753032
7.

Vesicular and Extra-Vesicular RNAs of Human Blood Plasma.

Savelyeva AV, Baryakin DN, Chikova ED, Kuligina EV, Richter VA, Semenov DV.

Adv Exp Med Biol. 2016;924:117-119.

PMID:
27753031
8.

Tumor-Specific Peptide, Selected from a Phage Peptide Library, Enhances Antitumor Activity of Lactaptin.

Nemudraya AA, Makartsova AA, Fomin AS, Nushtaeva AA, Koval OA, Richter VA, Kuligina EV.

PLoS One. 2016 Aug 11;11(8):e0160980. doi: 10.1371/journal.pone.0160980. eCollection 2016.

9.

Analysis of the efficiency of recombinant Escherichia coli strain cultivation in a gas-vortex bioreactor.

Savelyeva AV, Nemudraya AA, Podgornyi VF, Laburkina NV, Ramazanov YA, Repkov AP, Kuligina EV, Richter VA.

Biotechnol Appl Biochem. 2017 Sep;64(5):712-718. doi: 10.1002/bab.1527. Epub 2017 Mar 8.

PMID:
27506869
10.

Sensitivity of endometrial cancer cells from primary human tumor samples to new potential anticancer peptide lactaptin.

Koval OA, Sakaeva GR, Fomin AS, Nushtaeva AA, Semenov DV, Kuligina EV, Gulyaeva LF, Gerasimov AV, Richter VA.

J Cancer Res Ther. 2015 Apr-Jun;11(2):345-51. doi: 10.4103/0973-1482.157301.

11.

Regulatory role of small nucleolar RNAs in human diseases.

Stepanov GA, Filippova JA, Komissarov AB, Kuligina EV, Richter VA, Semenov DV.

Biomed Res Int. 2015;2015:206849. doi: 10.1155/2015/206849. Epub 2015 Apr 28. Review.

12.

A protective chimeric antibody to tick-borne encephalitis virus.

Baykov IK, Matveev AL, Stronin OV, Ryzhikov AB, Matveev LE, Kasakin MF, Richter VA, Tikunova NV.

Vaccine. 2014 Jun 17;32(29):3589-94. doi: 10.1016/j.vaccine.2014.05.012. Epub 2014 May 14.

PMID:
24837772
13.

Lactaptin induces p53-independent cell death associated with features of apoptosis and autophagy and delays growth of breast cancer cells in mouse xenografts.

Koval OA, Tkachenko AV, Fomin AS, Semenov DV, Nushtaeva AA, Kuligina EV, Zavjalov EL, Richter VA.

PLoS One. 2014 Apr 7;9(4):e93921. doi: 10.1371/journal.pone.0093921. eCollection 2014.

14.

Artificial box C/D RNAs affect pre-mRNA maturation in human cells.

Stepanov GA, Semenov DV, Savelyeva AV, Kuligina EV, Koval OA, Rabinov IV, Richter VA.

Biomed Res Int. 2013;2013:656158. doi: 10.1155/2013/656158. Epub 2013 Mar 31.

15.

A novel pro-apoptotic effector lactaptin inhibits tumor growth in mice models.

Koval OA, Fomin AS, Kaledin VI, Semenov DV, Potapenko MO, Kuligina EV, Nikolin VP, Nikitenko EV, Richter VA.

Biochimie. 2012 Dec;94(12):2467-74. doi: 10.1016/j.biochi.2012.08.017. Epub 2012 Aug 30.

PMID:
22968174
16.

Unbiased approach to profile the variety of small non-coding RNA of human blood plasma with massively parallel sequencing technology.

Semenov DV, Baryakin DN, Brenner EV, Kurilshikov AM, Vasiliev GV, Bryzgalov LA, Chikova ED, Filippova JA, Kuligina EV, Richter VA.

Expert Opin Biol Ther. 2012 Jun;12 Suppl 1:S43-51. doi: 10.1517/14712598.2012.679653. Epub 2012 Apr 18.

PMID:
22509727
17.

Recombinant analogs of a novel milk pro-apoptotic peptide, lactaptin, and their effect on cultured human cells.

Semenov DV, Fomin AS, Kuligina EV, Koval OA, Matveeva VA, Babkina IN, Tikunova NV, Richter VA.

Protein J. 2010 Apr;29(3):174-80. doi: 10.1007/s10930-010-9237-5.

PMID:
20232123
18.

Characterisation of circulating DNA by parallel tagged sequencing on the 454 platform.

van der Vaart M, Semenov DV, Kuligina EV, Richter VA, Pretorius PJ.

Clin Chim Acta. 2009 Nov;409(1-2):21-7. doi: 10.1016/j.cca.2009.08.011. Epub 2009 Aug 20.

PMID:
19699193
19.

Fragments of noncoding RNA in plasma of human blood.

Semenov DV, Baryakin DN, Kamynina TP, Kuligina EV, Richter VA.

Ann N Y Acad Sci. 2008 Aug;1137:130-4. doi: 10.1196/annals.1448.030.

PMID:
18837936
20.

Splicing by exon exclusion impaired by artificial box c/d RNA targeted to branch-point adenosine.

Semenov DV, Vratskih OV, Kuligina EV, Richter VA.

Ann N Y Acad Sci. 2008 Aug;1137:119-24. doi: 10.1196/annals.1448.037.

PMID:
18837934

Supplemental Content

Loading ...
Support Center